BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

767 related articles for article (PubMed ID: 19530580)

  • 1. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
    J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of percutaneous coronary intervention for unprotected left main coronary artery disease.
    Wu XM; Liu CP; Lin WC; Kao HL
    Int J Cardiol; 2010 Feb; 138(3):272-6. PubMed ID: 18804295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-eluting stent implantation for unprotected left main coronary artery disease: immediate and long-term outcomes].
    Zhang LT; Yuan Y; Huang XS; Feng L; Liu WQ; Han Y; Zhang J; Deng ZH; Dong JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2257-9. PubMed ID: 19114374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.
    Park DW; Seung KB; Kim YH; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Gwon HC; Jeong MH; Jang YS; Kim HS; Kim PJ; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ
    J Am Coll Cardiol; 2010 Jul; 56(2):117-24. PubMed ID: 20451344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome after management of unprotected left main in-stent restenosis after bare metal or drug-eluting stents.
    Chen SL; Xu B; Mintz G; Ye F; Zhang JJ; Kan J; Sun XW; Zhang AP; Chen JG; Qian J; Kwan TW
    Chin Med J (Engl); 2010 Apr; 123(7):794-9. PubMed ID: 20497666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery bypass grafting versus drug-eluting stent implantation for left main coronary artery disease (from a two-center registry).
    Kang SH; Park KH; Choi DJ; Park KW; Chung WY; Lim C; Kim KB; Kim HS
    Am J Cardiol; 2010 Feb; 105(3):343-51. PubMed ID: 20102946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of left main coronary trifurcation lesions with the paclitaxel drug-eluting stent: mid-term outcomes from a tertiary medical center.
    Shammas NW; Shammas GA; Jerin M; Parikh A; Coin K; Dippel E; Sharis P; Robken J
    J Invasive Cardiol; 2009 Jul; 21(7):321-5. PubMed ID: 19571341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is stenting a preferred option for unprotected left main coronary artery disease in the drug-eluting stent era?
    Park SJ
    Indian Heart J; 2007; 59(2 Suppl B):B105-12. PubMed ID: 19153426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term and long-term outcomes of treating bifurcation lesions with two drug eluting stent techniques].
    Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec; 34(12):1089-92. PubMed ID: 17274897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term mortality in patients unsuitable for surgical revascularization undergoing elective left main coronary artery angioplasty.
    Vignali L; Talanas G; Menozzi A; Cattabiani MA; Solinas E; Aurier E; Ardissino D
    Minerva Cardioangiol; 2008 Feb; 56(1):1-11. PubMed ID: 18432163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent implantation for the unprotected left main coronary artery. The long-term outcome of 62 patients.
    Peszek-Przybyła E; Buszman P; Białkowska B; Zurakowski L; Banasiewicz-Szkróbka I; Debiński M; Tendera M
    Kardiol Pol; 2006 Jan; 64(1):1-6; discussion 7. PubMed ID: 16444619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting.
    Wu X; Chen Y; Liu H; Teirstein PS; Kirtane AJ; Ge C; Song X; Chen X; Gu C; Huang F; Lv S
    Am J Cardiol; 2010 Jun; 105(12):1728-34. PubMed ID: 20538122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable long-term survival in patients undergoing stent PCI of unprotected left main coronary artery compared to predicted short-term prognosis of CABG estimated by EuroSCORE: clinical determinants of long-term outcome.
    Lehmann R; Spyridopoulos I; Kremer J; Zeiher AM; Schächinger V; Fichtlscherer S
    J Interv Cardiol; 2009 Aug; 22(4):311-9. PubMed ID: 19689656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
    Meliga E; Garcia-Garcia HM; Valgimigli M; Chieffo A; Biondi-Zoccai G; Maree AO; Cook S; Reardon L; Moretti C; De Servi S; Palacios IF; Windecker S; Colombo A; van Domburg R; Sheiban I; Serruys PW;
    J Am Coll Cardiol; 2008 Jun; 51(23):2212-9. PubMed ID: 18534266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of stenting for selective unprotected left main coronary artery disease: two-year follow-up of 416 patients].
    Han YL; Wang SL; Jing QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1109-12. PubMed ID: 17672992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of unprotected left main coronary artery stenting and the factors affecting the outcomes in Chinese.
    Gao RL; Xu B; Chen JL; Han YL; Li ZQ; Lü SZ; Qi XY; Huo Y; Wang LF; Chen JZ; Shen WF; Fang WY; Jia SQ;
    Chin Med J (Engl); 2006 Jan; 119(1):14-20. PubMed ID: 16454976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
    Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.